KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $80.90 $93.35 Friday, 26th Apr 2024 BMRN stock ended at $80.91. This is 1.53% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 2.71% from a day low at $80.90 to a day high of $83.09.
90 days $80.90 $94.15
52 weeks $76.02 $99.55

Historical BioMarin Pharmaceutical Inc. prices

Date Open High Low Close Volume
Mar 07, 2016 $87.70 $89.84 $86.18 $88.22 1 761 600
Mar 04, 2016 $89.73 $89.83 $86.47 $86.67 1 744 500
Mar 03, 2016 $88.91 $90.99 $88.28 $89.57 2 802 800
Mar 02, 2016 $87.44 $90.34 $84.00 $87.44 2 080 500
Mar 01, 2016 $82.50 $88.04 $81.03 $87.57 2 372 900
Feb 29, 2016 $80.75 $84.90 $80.62 $81.87 2 410 200
Feb 26, 2016 $76.64 $82.11 $74.80 $80.14 2 299 000
Feb 25, 2016 $76.92 $78.91 $74.64 $76.41 1 840 500
Feb 24, 2016 $74.31 $76.52 $72.96 $76.34 1 465 100
Feb 23, 2016 $78.11 $80.25 $75.48 $75.61 1 764 300
Feb 22, 2016 $79.05 $81.90 $76.75 $78.49 1 620 500
Feb 19, 2016 $74.55 $77.91 $73.28 $77.70 1 983 100
Feb 18, 2016 $78.36 $78.80 $74.45 $74.87 1 830 300
Feb 17, 2016 $75.16 $79.63 $73.61 $77.81 2 542 100
Feb 16, 2016 $72.11 $74.40 $71.49 $74.26 2 437 800
Feb 12, 2016 $68.00 $71.25 $67.07 $70.08 2 152 500
Feb 11, 2016 $65.43 $68.89 $65.03 $67.26 1 641 700
Feb 10, 2016 $65.96 $70.76 $65.57 $67.02 1 853 400
Feb 09, 2016 $63.59 $67.40 $62.12 $65.11 2 450 700
Feb 08, 2016 $68.17 $68.17 $63.71 $64.74 1 794 000
Feb 05, 2016 $70.75 $71.58 $66.20 $68.41 2 222 700
Feb 04, 2016 $71.50 $73.78 $69.57 $71.15 2 227 900
Feb 03, 2016 $72.37 $74.69 $67.53 $71.91 2 201 100
Feb 02, 2016 $74.44 $76.00 $71.78 $72.04 1 552 900
Feb 01, 2016 $73.81 $76.70 $73.27 $75.65 2 329 500
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT